55292-133 : Signifor .9 mg/ml Subcutaneous Injection
NDC: | 55292-133 |
Labeler: | Recordati Rare Diseases, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Signifor |
Dosage Form: | Subcutaneous Injection |
Application #: | NDA200677 |
Rev. Date: |
NDC Package Codes:
- 55292-133-60: 60 PACKAGE IN 1 BOX (55292‑133‑60) > 6 AMPULE IN 1 PACKAGE (55292‑133‑06) > 1 ML IN 1 AMPULE (55292‑133‑01)
Active Ingredients:
- Pasireotide
Dosage Strength:
- .9 mg/mL
Pharmaceutical Classes:
- Somatostatin Analog [EPC]
- Somatostatin Receptor Agonists [MoA]
Related Products:
Based on records with the same trade name.- 55292-131 Signifor .3 mg/ml Subcutaneous Injection by Recordati Rare Diseases, Inc.
- 55292-132 Signifor .6 mg/ml Subcutaneous Injection by Recordati Rare Diseases, Inc.
- 0078-0633 Signifor .3 mg/ml Subcutaneous Injection by Novartis Pharmaceuticals Corporation
- 0078-0634 Signifor .6 mg/ml Subcutaneous Injection by Novartis Pharmaceuticals Corporation
- 0078-0635 Signifor .9 mg/ml Subcutaneous Injection by Novartis Pharmaceuticals Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 55292-132Next: 55292-139 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.